Autoimmune lymphoproliferative syndrome: genes and variants
Explore variant evidence for Autoimmune lymphoproliferative syndrome across 4 analyzed proteins (FAS, KRAS, CASP8, NRAS). Linked ClinVar records include 28 pathogenic or likely pathogenic variants, 265 variants of uncertain significance and 14 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Source labels are pooled across this disease family.
Data updated 2026-10-21. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Autoimmune lymphoproliferative syndrome
FAS: Tumor necrosis factor receptor superfamily member 6
Its engagement by FAS ligand assembles a death-inducing signaling complex that triggers caspase-mediated apoptosis, particularly in activated lymphocytes. Loss-of-function variants can cause autoimmune lymphoproliferative syndrome by preventing normal contraction of immune responses.
21 ClinVar pathogenic / likely pathogenic and 152 uncertain variants in FAS have source records linked to Autoimmune lymphoproliferative syndrome. Association strength is not clinical gene validity.
KRAS: GTPase KRas
A small GTPase that acts as a molecular switch in the RAS-MAPK signaling pathway. By cycling between GDP- and GTP-bound states, it relays growth and survival signals, and activating KRAS variants are common drivers of cancer.
5 ClinVar pathogenic / likely pathogenic and 3 uncertain variants in KRAS have source records linked to Autoimmune lymphoproliferative syndrome. Association strength is not clinical gene validity.
CASP8: Caspase-8
It initiates death-receptor-mediated apoptosis but also regulates lymphocyte activation and inflammatory signaling. Biallelic loss-of-function variants can cause immunodeficiency with defective apoptosis and lymphocyte homeostasis, while somatic pathway alterations can promote cancer-cell survival.
2 ClinVar pathogenic / likely pathogenic and 123 uncertain variants in CASP8 have source records linked to Autoimmune lymphoproliferative syndrome. Association strength is not clinical gene validity.
NRAS: GTPase NRas
Its active GTP-bound state drives RAF-MEK-ERK and PI3K signaling downstream of growth-factor receptors. Somatic activating variants are common drivers of melanoma, leukemia, and other cancers, while germline activating variants can cause Noonan syndrome.
0 ClinVar pathogenic / likely pathogenic and 1 uncertain variants in NRAS have source records linked to Autoimmune lymphoproliferative syndrome. Association strength is not clinical gene validity.
Where Autoimmune lymphoproliferative syndrome variants cluster
- FAS Death (positions 230–314): 14 of 21 ClinVar pathogenic / likely pathogenic variants, 2.6× more than its size predicts (a length-based count, not a validated hotspot).
ClinVar pathogenic and likely pathogenic variants linked to Autoimmune lymphoproliferative syndrome
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| FAS R250Q | 250 | Death | Pathogenic / likely pathogenic (★★) |
| KRAS A146P | 146 | Pathogenic / likely pathogenic (★★) | |
| FAS D260N | 260 | Death | Pathogenic / likely pathogenic (★★) |
| FAS I259T | 259 | Death | Pathogenic / likely pathogenic (★★) |
| KRAS G12A | 12 | Pathogenic / likely pathogenic (★★) | |
| KRAS A146T | 146 | Pathogenic / likely pathogenic (★★) | |
| FAS G253V | 253 | Death | Pathogenic / likely pathogenic (★★) |
| KRAS G13C | 13 | Pathogenic / likely pathogenic (★★) | |
| FAS H111R | 111 | TNFR-Cys 2 | Pathogenic / likely pathogenic (★★) |
| FAS L179R | 179 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| FAS L7P | 7 | Pathogenic / likely pathogenic (★★) | |
| KRAS D119N | 119 | Pathogenic / likely pathogenic (★★) | |
| CASP8 R233W | 233 | Pathogenic / likely pathogenic (★★) | |
| CASP8 R248W | 248 | Pathogenic / likely pathogenic (★★) | |
| FAS D260G | 260 | Death | Pathogenic / likely pathogenic (★) |
| FAS R250P | 250 | Death | Pathogenic / likely pathogenic (★) |
| FAS D260V | 260 | Death | Pathogenic / likely pathogenic (★) |
| FAS K263N | 263 | Death | Pathogenic / likely pathogenic (★) |
| FAS E272K | 272 | Death | Pathogenic / likely pathogenic (★) |
| FAS E272Q | 272 | Death | Pathogenic / likely pathogenic (★) |
| FAS D108G | 108 | TNFR-Cys 2 | Pathogenic / likely pathogenic (★) |
| FAS C135Y | 135 | TNFR-Cys 3 | Pathogenic / likely pathogenic (★) |
| FAS I262M | 262 | Death | Pathogenic / likely pathogenic (★) |
| FAS G286E | 286 | Death | Pathogenic / likely pathogenic (★) |
| FAS E114V | 114 | TNFR-Cys 2 | Pathogenic / likely pathogenic (★) |
| FAS L180F | 180 | Transmembrane | Pathogenic / likely pathogenic (★) |
| FAS G238V | 238 | Death | Pathogenic / likely pathogenic (★) |
| FAS T241K | 241 | Death | Pathogenic / likely pathogenic (★) |
Which prediction tools work for Autoimmune lymphoproliferative syndrome
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- REVEL: 100 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CATVariant: 97 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- PolyPhen-2: 95 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CADD: 92 out of 100
- AlphaMissense: 91 out of 100
- ESM1b (LLR): 90 out of 100
- SIFT: 84 out of 100
- phyloP: 82 out of 100
- Pangolin: 48 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- SpliceAI: 44 out of 100 (learned from overlapping clinical labels, so this is optimistic)
Same protein, different disease
- FAS-related autoimmune lymphoproliferative syndrome also has ClinVar records linked to FAS variants; they fall in the same places as the Autoimmune lymphoproliferative syndrome variants (4 pathogenic / likely pathogenic).
- SQUAMOUS CELL CARCINOMA, BURN SCAR-RELATED, SOMATIC also has ClinVar records linked to FAS variants; they fall partly in the same places as the Autoimmune lymphoproliferative syndrome variants (3 pathogenic / likely pathogenic).
- RASopathy also has ClinVar records linked to KRAS variants; they fall mostly in different places as the Autoimmune lymphoproliferative syndrome variants (23 pathogenic / likely pathogenic).
- Noonan syndrome also has ClinVar records linked to KRAS variants; they fall mostly in different places as the Autoimmune lymphoproliferative syndrome variants (16 pathogenic / likely pathogenic).
- Cardiofaciocutaneous syndrome also has ClinVar records linked to KRAS variants; they fall mostly in different places as the Autoimmune lymphoproliferative syndrome variants (9 pathogenic / likely pathogenic).
- Non-small cell lung carcinoma also has ClinVar records linked to KRAS variants; they fall mostly in different places as the Autoimmune lymphoproliferative syndrome variants (5 pathogenic / likely pathogenic).
- Cardio-facio-cutaneous syndrome also has ClinVar records linked to KRAS variants; they fall mostly in different places as the Autoimmune lymphoproliferative syndrome variants (4 pathogenic / likely pathogenic).
Diseases related to Autoimmune lymphoproliferative syndrome
- RASopathy, also linked to KRAS and NRAS
- Noonan syndrome, also linked to KRAS and NRAS
- Noonan syndrome and Noonan-related syndrome, also linked to KRAS and NRAS
- Cardiofaciocutaneous syndrome, also linked to KRAS and NRAS
- Acute myeloid leukemia, also linked to KRAS and NRAS
- Colorectal cancer, also linked to KRAS and NRAS
- Vascular malformation, also linked to KRAS and NRAS
- Multiple myeloma, also linked to KRAS and NRAS
- Myelomonocytic leukemia, also linked to KRAS and NRAS
- Linear nevus sebaceus syndrome, also linked to KRAS and NRAS
- Hypertrophic cardiomyopathy, also linked to NRAS
- Cardio-facio-cutaneous syndrome, also linked to KRAS
Frequently asked questions
Which genes have records linked to Autoimmune lymphoproliferative syndrome?
This view contains 4 analyzed proteins: FAS, KRAS, CASP8, NRAS. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 28 pathogenic or likely pathogenic variants, 265 variants of uncertain significance and 14 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 354 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center